Registered entities
Avalyn Pharma Inc.
Reg. No. 32094123372United States
Innovation
10 patent families (7 granted) — focus: Human necessities; filing pace slowing. Cited 1,440 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 2 |
Social engagement
Social engagement: 9.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
24 investors on record; lead investors include F-Prime Capital, Norwest, Edmond de Rothschild, Perceptive Advisors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 54% |
| Private equity | 3 | 13% |
| Accelerator & incubator | 1 | 4% |
| Bank & private debt | 2 | 8% |
| Other / undisclosed | 5 | 21% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
20 Nov 2025 · Director, Supply Chain · Boston
30 Aug 2025 · Senior Clinical Data Manager · Cambridge
Based on job postings tracked across public sources.
Recent activity
17 Jun 2026
Milestone
regulatory
4 Jun 2026
Event
Pulmonary Clinical Trials (PCT) Workshop
27 May 2026
Event
Jefferies Global Healthcare Conference